SUNation Energy Announces Reverse Stock Split

RONKONKOMA, N.Y., April 16, 2025 (GLOBE NEWSWIRE) — SUNation Energy, Inc. (Nasdaq: SUNE) (“SUNation” or “the Company”), a leading provider of sustainable solar energy and backup power solutions for households, businesses, and municipalities, today announced that its Board of Directors approved a 200 – for 1 reverse stock split of the Company’s outstanding common stock effective 12:01 a.m. Eastern Time on April 21, 2025.

The Company’s common stock will continue to trade under the symbol “SUNE” and it is expected to open for trading on Nasdaq on April 21, 2025 on a post-split basis. The new CUSIP number for the common stock following the reverse stock split will be 72303P503.

The ratio of the reverse stock split is within the range approved by shareholders at a Special Meeting of Shareholders held on April 3, 2025. The reverse stock split is primarily intended to increase the market price per share of the Company’s common stock to regain compliance with the minimum bid price required for continued listing on The Nasdaq Capital Market.

Upon the effectiveness of the reverse stock split, every 200 shares of issued and outstanding Company common stock at the close of business on April 17, 2025 will be automatically combined into one issued and outstanding share of common stock, with no change in par value per share. The total shares outstanding stands at 672,799,910 as of April 11, 2025. The split, once effective, will result in there being approximately 3,364,000 shares outstanding immediately thereafter.

The reverse stock split does not reduce the number of shares of the Company’s authorized common stock. No fractional shares will be issued as a result of the reverse stock split and all such fractional interests will be rounded up to the nearest whole number of shares of common stock. The reverse stock split will affect all common shareholders uniformly and will not alter any shareholder’s percentage interest in the Company’s common stock, except to the extent that the reverse stock split results in some shareholders experiencing an adjustment of a fractional share as described above.

Shareholders holding their shares electronically in book-entry form are not required to take any action to receive the post-split shares. Shareholders holding physical share certificates will receive information from EQ Shareowner Services, the Company’s transfer agent, regarding the process for exchanging their shares of common stock. Shareholders with questions may contact the Company’s transfer agent by calling 800-401-1957.

Additional information about the reverse stock split can be found in the Company’s definitive proxy statement (the “Proxy Statement”) filed with the Securities and Exchange Commission (the “SEC”) on March 10, 2025, which is available at the SEC’s website, www.sec.gov.

About SUNation Energy, Inc.

SUNation Energy, Inc. is focused on growing leading local and regional solar, storage, and energy services companies nationwide. Our vision is to power the energy transition through grass-roots growth of solar electricity paired with battery storage. Our portfolio of brands (SUNation, Hawaii Energy Connection, E-Gear) provide homeowners and businesses of all sizes with an end-to-end product offering spanning solar, battery storage, and grid services. SUNation Energy, Inc.’s largest markets include New York, Florida, and Hawaii, and the company operates in three (3) states.

Forward Looking Statements 

Our prospects here at SUNation Energy Inc. are subject to uncertainties and risks. This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. The Company intends that such forward-looking statements be subject to the safe harbor provided by the foregoing Sections. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this presentation. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words “believes”, “expects”, “anticipates”, “intends”, “estimates”, “plans”, “projects”, “should”, or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. We caution readers not to place undue reliance upon any such forward-looking statements. The Company does not undertake to publicly update or revise forward-looking statements, whether because of new information, future events or otherwise. Additional information respecting factors that could materially affect the Company and its operations are contained in the Company’s filings with the SEC which can be found on the SEC’s website at www.sec.gov.

Contacts:
Scott Maskin
Chief Executive Officer
+1 (631) 823-7131
[email protected]
 
   
SUNation Energy Investor Relations
[email protected]
 



Treasure Global Inc. Secures Exclusive Rights to Launch Mezzofy’s USD40 Billion Coupon Platform in Malaysia

Scalable Rollout Targets USD2 to 4 Million in Recurring Annual Revenue Within First Year

KUALA LUMPUR, Malaysia, April 16, 2025 (GLOBE NEWSWIRE) — Treasure Global Inc. (NASDAQ: TGL) (“Treasure Global” or the “Company”), is pleased to announce an exclusive strategic partnership with Mezzofy (Hong Kong) Limited (“Mezzofy”), a market leader in digital coupon management solutions. Under this agreement, Treasure Global becomes the sole distributor of Mezzofy’s platform in Malaysia, positioning the Company to capture approximately USD2 to 4 million in recurring annual revenue within the first 12 months of rollout.

Since its inception, Mezzofy’s cloud-based “Coupon-as-a-Service” (CaaS) platform has facilitated over USD40 billion in digital coupon transactions across 15 markets (as of 2024), serving high-profile merchants including Coffee Concepts (Hong Kong) Limited (“Starbucks (Hong Kong)”), Sa Sa International Holding Limited, and others. The platform enables businesses to create, distribute, and manage digital coupons instantly – without infrastructure investment – unlocking fast, scalable, and cost-effective customer engagement.

Through this exclusive partnership, Treasure Global will serve as Mezzofy’s sole distributor in Malaysia. Leveraging its deep expertise in digital innovation and a strong local presence, Treasure Global will focus on merchant onboarding at scale. The partnership is expected to generate significant synergies between both companies while tapping into Malaysia’s fast-growing demand for digital loyalty and coupon solutions. Treasure Global anticipates this rollout will contribute USD2 to 4 million in recurring annual revenue, driven by a high-margin platform model and long-term enterprise adoption.

As Malaysia continues to embrace digital transformation – supported by high smartphone penetration and government initiatives to accelerate digital economy growth – this partnership is well-positioned to meet the market’s evolving needs. Treasure Global aims to take a leading role in shaping the country’s next-generation digital rewards ecosystem.

According to Business Research Insights, the global digital coupon market is projected to reach approximately USD41 billion by 2033, growing at a compound annual growth rate (CAGR) of 18.33% from 2025 to 2033. The rapid adoption of smartphones and the expansion of the e-commerce sector are key drivers of this growth. Additionally, Market Research highlights that the convenience and cost-effectiveness of digital coupons continue to drive their popularity among both consumers and businesses.

“We are excited to enter the Malaysian market with Treasure Global as our exclusive partner. With a strong regional footprint and over USD40 billion in digital coupon transactions to date, our platform has demonstrated scalability and reliability across Asia. Treasure Global’s deep understanding of Malaysia’s digital ecosystem makes them the ideal partner to drive rapid adoption and merchant engagement,” said Dicky Ying, CEO of Mezzofy.

“This partnership marks a transformative milestone in our growth strategy. By leading Mezzofy’s rollout in Malaysia, we are delivering a proven, plug-and-play solution with immediate go-to-market impact. With full control over deployment and merchant onboarding, this scalable, high-margin platform positions us to generate strong recurring annual revenue and create lasting enterprise value,” said Carlson Thow, CEO of Treasure Global Inc.

About Mezzofy:

Mezzofy is a Hong Kong-based leader in digital coupon management. Its “Coupon-as-a-Service” (CaaS) platform enables businesses to easily create, distribute, and manage digital coupons without the need for costly infrastructure. Mezzofy’s scalable, cloud-based solutions enhance customer engagement, boost sales, and streamline operations, helping businesses modernize their marketing strategies.

Visit https://mezzofy.com/ for more information.

About Treasure Global:

Treasure Global is a leading Malaysian solutions provider, specializing in the development of innovative technology platforms that drive digital transformation. Its flagship product, the ZCITY Super App, integrates e-payment solutions with customer rewards, fostering a seamless digital ecosystem. As of March 2025, ZCITY Super App has attracted over 2.7 million registered users, positioning Treasure Global as a key player in Malaysia’s digital economy.

Visit treasureglobal.co for more information.


Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements reflect the Company’s current expectations, assumptions, and projections about future events and are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Forward-looking statements typically include terminology such as “anticipates,” “believes,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” or similar expressions.

Factors that could cause actual results to differ materially include, without limitation, the Company’s ability to expand its e-commerce platform, customer acceptance of new products and services, changes in economic conditions affecting its operations, the impact of global health crises, supply chain disruptions, competition, and regulatory risks related to data privacy and security. These risks, along with other factors, are discussed in more detail in the Company’s filings with the U.S. Securities and Exchange Commission.

The forward-looking statements in this press release speak only as of the date hereof. The Company assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

CONTACT

Investor and media contact:

Chin Sook Lee
Chief Financial Officer
Treasure Global Inc.
[email protected]



Veeco Announces Date for First Quarter Financial Results and Conference Call

PLAINVIEW, N.Y., April 16, 2025 (GLOBE NEWSWIRE) — Veeco Instruments Inc. (NASDAQ: VECO) plans to release its first quarter 2025 financial results after the market closes on Wednesday, May 7, 2025. The company will host a conference call to review these results starting at 5:00 PM ET that day.

To join the call, dial 1-877-407-8029 (toll free) or 1-201-689-8029. Participants may also access a live webcast of the call by visiting the investor relations section of Veeco’s website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website beginning at 8:00 PM ET that same evening.



About Veeco



Veeco (NASDAQ: VECO) is an innovative manufacturer of semiconductor process equipment. Our laser annealing, ion beam, single wafer etch & clean, lithography, metal organic chemical vapor deposition (MOCVD), and chemical vapor deposition (CVD) technologies play an integral role in the fabrication and packaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, Veeco holds leading technology positions in the markets we serve. To learn more about Veeco’s systems and service offerings, visit www.veeco.com.

To the extent that this news release discusses expectations or otherwise makes statements about the future, such statements are forward-looking and are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include the risks discussed in the Business Description and Management’s Discussion and Analysis sections of Veeco’s Annual Report on Form 10-K for the year ended December 31, 2024 and in our subsequent quarterly reports on Form 10-Q, current reports on Form 8-K and press releases. Veeco does not undertake any obligation to update any forward-looking statements to reflect future events or circumstances after the date of such statements.

Veeco Contacts:                                

Investors: Anthony Pappone | (516) 500-8798 | [email protected]
Media: Brenden Wright | (516) 714-1202 | [email protected]

        



TNF Pharmaceuticals Delivers Platform Presentation of Oral TNF-Alpha Inhibitor Isomyosamine at British Geriatrics Society’s Spring Meeting 2025

TNF Pharmaceuticals Delivers Platform Presentation of Oral TNF-Alpha Inhibitor Isomyosamine at British Geriatrics Society’s Spring Meeting 2025

Positive clinical data validates commencement of a larger Phase 2b clinical trial in elderly patients post-hip fracture

Drug shown to decrease biomarkers associated with TNF-alpha activation in elderly patients with sarcopenia

BALTIMORE–(BUSINESS WIRE)–
TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, announced today that a platform presentation of an abstract titled “Isomyosamine for the Treatment of Sarcopenia in Older Adults” was delivered by Mitchell Glass, M.D., President and Chief Medical Officer of TNF, at the British Geriatrics Society (BGB) Spring Meeting 2025, held April 9-11, 2025, in Belfast, Ireland and online.

During his presentation, Dr. Glass spoke about the Company’s small-molecule TNF-alpha (TNF-α) inhibitor, isomyosamine, which has shown potential for regulating pro-inflammatory cytokines associated with sarcopenia. In response to a question, he emphasized the Company’s commitment to sarcopenia as an initial indication, including muscle wasting as an effect of treatment with GLP-1 agonists. He also commented on the Company’s plans to extend Phase 3 into the UK and Europe.

“An earlier Phase 2 study of isomyosamine demonstrated its safety and tolerability in elderly patients with sarcopenia, with significant reductions in inflammatory biomarkers such as TNF-α, IL-6, and soluble TNF receptor 1 (sTNFR1). We are currently enrolling patients in a larger Phase 2b clinical trial that will investigate isomyosamine’s effect on cellular inflammation and recovery of ambulation speed in elderly patients post-hip fracture. An increased sample size and more frequent dosing in the follow-up trial will enable us to better evaluate the drug’s potential to improve both clinical and biochemical outcomes in sarcopenic patients,” Dr. Glass explained.

The British Geriatrics Society is the membership association for professionals specializing in the healthcare of older people across the UK. Founded in 1947, BGS has over 5,000 members, and it is the only Society in the UK offering specialist expertise in the wide range of healthcare needs of older people.

About Isomyosamine

Isomyosamine (ICD-10-CM code M62.84) is a novel plant alkaloid small molecule shown to regulate the immuno-metabolic system through the modulation of numerous pro-inflammatory cytokines including TNF-alpha (TNF-α), an immune cell signaling protein and inflammatory cytokine responsible for inducing and maintaining the inflammatory process. TNF-α is located upstream of a cascade of molecular signals that induces inflammation and helps activate the process of aging. Many in vivo and in vitro studies have shown that TNFα plays a causative role in the pathogenesis of various age-related diseases.

About TNF Pharmaceuticals, Inc.

TNF Pharmaceuticals, Inc. (Nasdaq: TNFA), a clinical stage pharmaceutical company committed to extending healthy lifespan, is focused on developing two novel therapeutic platforms that treat the causes of disease rather than only addressing the symptoms. Isomyosamine is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-α, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. Isomyosamine is being developed to treat diseases and disorders marked by acute or chronic inflammation. The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy. Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve upon the rapidly growing CBD market, which includes both FDA approved drugs and CBD products not currently regulated as drugs. For more information, visit www.tnfpharma.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release may contain forward-looking statements. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to be materially different from any expected future results, performance, or achievements. Forward-looking statements speak only as of the date they are made and neither the Company nor its affiliates assume any duty to update forward-looking statements. Words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “may,” “plan,” “will,” “would’’ and other similar expressions are intended to identify these forward-looking statements. Examples of such statements include, but are not limited to, statements regarding the Company’s ability to launch and the timing of the Company’s planned trial of isomyosamine as a treatment for GLP-1-induced sarcopenia and frailty. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, without limitation: the Company’s ability to maintain compliance with the Nasdaq Stock Market’s listing standards; the timing of, and the Company’s ability to, obtain and maintain regulatory approvals for clinical trials of the Company’s pharmaceutical candidates; the timing and results of the Company’s planned clinical trials for its pharmaceutical candidates; the amount of funds the Company requires for its pharmaceutical candidates; increased levels of competition; changes in political, economic or regulatory conditions generally and in the markets in which the Company operates; the Company’s ability to retain and attract senior management and other key employees; the Company’s ability to quickly and effectively respond to new technological developments; and the Company’s ability to protect its trade secrets or other proprietary rights, operate without infringing upon the proprietary rights of others and prevent others from infringing on the Company’s proprietary rights. A discussion of these and other factors with respect to the Company is set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, filed by the Company on April 11, 2025, and subsequent reports that the Company files with the Securities and Exchange Commission. Forward-looking statements speak only as of the date they are made, and the Company disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Contact:

Robert Schatz

(646) 421-9523

[email protected]

www.tnfpharma.com

KEYWORDS: North America United States Ireland United Kingdom Europe Maryland

INDUSTRY KEYWORDS: Research Seniors Clinical Trials Other Health Biotechnology General Health Pharmaceutical Consumer Health Science

MEDIA:

Logo
Logo

Shift4 Announces Date of First Quarter Earnings Results and Upcoming Conference Participation

Shift4 Announces Date of First Quarter Earnings Results and Upcoming Conference Participation

CENTER VALLEY, Pa.–(BUSINESS WIRE)–
Shift4 (NYSE: FOUR), the leader in integrated payments and commerce technology, today announced the date for the release of its first quarter 2025 financial results, as well as its upcoming participation in investor conferences.

Q1 2025 Earnings Conference Call

Shift4 will release its first quarter 2025 financial results pre-market open on Tuesday, April 29, 2025. Management will also host a conference call at 8:30am ET to review these results.

Conference Call Details

Toll-free dial-in:

+1-877-407-0613

Toll dial-in:

+1-201-689-8051

The earnings conference call will also be webcast and interested parties can join the webcast through Shift4’s website at: https://investors.shift4.com

X Spaces Simulcast

In addition to the webcast, an audio of the earnings call will be simulcast via X Spaces. Follow @Shift4 on X (formerly Twitter) for additional information on how to access the simulcast.

Upcoming Conference Participation:

May 20, 2025 – Management will participate in a fireside chat at the 2025 Barclays FinTech Conference at 9:45AM ET in New York, NY. Management will also be available for one-on-one and small group meetings. The fireside chat will be webcast live and interested parties can join the webcast from Shift4’s website at: https://investors.shift4.com

June 10, 2025 – Management will be available for one-on-one and small group meetings at the 2025 D.A. Davidson Tech Conference in Nashville, TN.

About Shift4

Shift4 (NYSE: FOUR) is boldly redefining commerce by simplifying complex payments ecosystems across the world. As the leader in commerce-enabling technology, Shift4 powers billions of transactions annually for hundreds of thousands of businesses in virtually every industry. For more information, visit shift4.com.

Investor Relations

Thomas McCrohan

EVP, Strategy and Investor Relations

Shift4

(484) 735-0779

[email protected]

Paloma Main

Director, Strategy and Investor Relations

Shift4

(484) 954-5768

[email protected]

Media Contacts

Nate Hirshberg

SVP, Marketing

Shift4

[email protected]

KEYWORDS: United States North America Tennessee New York Pennsylvania

INDUSTRY KEYWORDS: Payments Electronic Commerce Professional Services Technology Fintech

MEDIA:

Cadence to Acquire Arm Artisan Foundation IP Business

Cadence to Acquire Arm Artisan Foundation IP Business

Transaction will augment Cadence’s expanding design IP portfolio and accelerate growth opportunities

SAN JOSE, Calif.–(BUSINESS WIRE)–
Cadence (Nasdaq: CDNS) today announced that it has entered into a definitive agreement with Arm (Nasdaq: ARM) to acquire Arm’s Artisan foundation IP business, consisting of standard cell libraries, memory compilers, and general-purpose I/Os (GPIOs) optimized for advanced process nodes at the leading foundries. The transaction will augment Cadence’s expanding design IP offerings, anchored by a leading portfolio of protocol and interface IP, memory interface IP, SerDes IP at the most advanced nodes, and embedded security IP from the pending Secure-IC acquisition.

By increasing its footprint in SoC designs, Cadence is reinforcing its commitment to continuously accelerate customers’ time to market and to optimize their cost, power and performance on the world’s leading foundry processes. Cadence will acquire the Arm Artisan foundation IP business through an asset purchase agreement with a concurrent technology license agreement, to be signed at closing and subject to any existing rights. As part of the transaction, Cadence will acquire a highly talented and experienced engineering team that is well respected in the industry and can help accelerate development of both related and new IP products.

“During its 25-year history, Arm’s Artisan IP has established a strong presence and reputation in the global ecosystem of foundries and SoC partners. With the expected addition of the Artisan IP business and team, Cadence will enter the foundation IP market, enabling us to capitalize on new growth opportunities,” said Boyd Phelps, senior vice president and general manager of the Silicon Solutions Group at Cadence. “In doing so, we will gain key technology and expertise to augment our design services and chiplet offerings, enabling us to deliver on our comprehensive IP strategy and provide greater value to our customers. By leveraging the full Cadence stack of IP, libraries, tools, and services, we strive to improve PPA while growing this foundation IP business.”

“We are committed to ensuring that the foundational physical IP needed to deploy Arm technology across all markets continues to be available to the ecosystem,” said Kevork Kechichian, executive vice president, Solutions Engineering, Arm. “The Artisan brand is well established and we believe this technology will continue to play a significant role in the semiconductor industry in the future, and that Cadence is an ideal partner to take it forward.”

The transaction is anticipated to close in the third quarter of 2025, subject to receipt of regulatory approvals and other customary closing conditions. The acquisition is expected to be immaterial to revenue and earnings this year.

About Cadence

Cadence is a market leader in AI and digital twins, pioneering the application of computational software to accelerate innovation in the engineering design of silicon to systems. Our design solutions, based on Cadence’s Intelligent System Design strategy, are essential for the world’s leading semiconductor and systems companies to build their next-generation products from chips to full electromechanical systems that serve a wide range of markets, including hyperscale computing, mobile communications, automotive, aerospace, industrial, life sciences and robotics. In 2024, Cadence was recognized by the Wall Street Journal as one of the world’s top 100 best-managed companies. Cadence® solutions offer limitless opportunities—learn more at www.cadence.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding pending transactions, the anticipated timeline and closing of the pending transactions, talent, technologies and product offerings, business strategy, plans and opportunities, industry and market trends and the expected benefits and impact of pending transactions and combined businesses. Forward-looking statements are based on current expectations, estimates, forecasts and projections. Words such as “expect,” “anticipate,” “should,” “believe,” “hope,” “target,” “project,” “goals,” “estimate,” “potential,” “predict,” “may,” “will,” “might,” “could,” “intend,” “shall” and variations of these terms and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are subject to a number of risks, uncertainties and other factors, many of which are outside the applicable parties’ control. For example, the markets for relevant products and services may develop more slowly than expected or than they have in the past; operating results and cash flows may fluctuate more than expected; closing conditions, including required regulatory approvals, may not be obtained in a timely manner or at all; Cadence may fail to successfully acquire and integrate the acquired assets and licensed technology; the applicable parties may fail to realize the anticipated benefits of the proposed transactions; the applicable parties may incur unanticipated costs or other liabilities in connection with pending transactions; the potential impact of the announcement or consummation of pending transactions on relationships with third parties, including employees, customers, partners and competitors; the applicable parties may be unable to motivate and retain key personnel; changes in or failure to comply with legislation or government regulations could affect the closing of pending transactions or post-closing operations and results of operations; and macroeconomic and geopolitical conditions could deteriorate. Further information on potential factors that could affect pending transactions or otherwise impact the anticipated benefits of pending and recent transactions is included in and the applicable parties’ most recent annual report on Form 10-K or Form F-20, as applicable, and their other filings with the Securities and Exchange Commission. The forward-looking statements included in this press release represent Arm’s and Cadence’s views as of the date of this press release, and Arm and Cadence disclaims any obligation to update any of them publicly in light of new information or future events.

© 2025 Cadence Design Systems, Inc. All rights reserved worldwide. Cadence, the Cadence logo and the other Cadence marks found at www.cadence.com/go/trademarks are trademarks or registered trademarks of Cadence Design Systems, Inc. All other trademarks are the property of their respective owners.

Category: Featured

For more information, please contact:

Cadence Newsroom

408-944-7039

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Software Hardware Electronic Design Automation Artificial Intelligence Engineering Technology Semiconductor Manufacturing

MEDIA:

Logo
Logo

Sonnet Releases Virtual Investor “What This Means” Segment

– Raghu Rao, Interim Chief Executive Officer and Dr. Richard Kenney, Chief Medical Officer, of Sonnet discuss the recently announced safety data related to SON-1010

– 

Watch the “What This Means” video here

PRINCETON, N.J., April 16, 2025 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the “Company” or “Sonnet”), a clinical-stage company developing immunotherapeutic drugs targeted to the tumor microenvironment (TME), today announced that members of the Sonnet management team participated in a Virtual Investor “What This Means” segment.

As part of the segment, Raghu Rao, Interim Chief Executive Officer and Dr. Richard Kenney, Chief Medical Officer, discussed the recently announced positive safety results of SON-1010 (IL12-FHAB) at the highest dose combined with atezolizumab being evaluated in the Phase 1b/2a clinical trial in adult patients with advanced solid tumors or platinum-resistant ovarian cancer (PROC) (the SB221 study). Mr. Rao and Dr. Kenney also provided insight into next steps for the program.

The Virtual Investor “What This Means” segment featuring Sonnet is now available here.

About Sonnet BioTherapeutics Holdings, Inc.

Sonnet is an oncology-focused biotechnology company with a proprietary platform for developing targeted biologic drugs with single or bifunctional action. Known as FHAB (Fully Human Albumin-Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. Sonnet’s FHAB was designed to specifically target tumor and lymphatic tissue, with an improved therapeutic window for optimizing the safety and efficacy of immune modulating biologic drugs. FHAB platform is the foundation of a modular, plug-and-play construct for potentiating a range of large molecule therapeutic classes, including cytokines, peptides, antibodies and vaccines.

Sonnet’s lead program, SON-1010, or IL-12-FHAB, is in development for the treatment of solid tumors, certain types of sarcoma, and ovarian cancer. SON-1010 is being evaluated in an ongoing Phase 1/2a study through a Master Clinical Trial and Supply Agreement, along with ancillary Quality and Safety Agreements, with Roche in combination with atezolizumab (Tecentriq®) for the treatment of platinum-resistant ovarian cancer (PROC) (NCT05756907). The Company is also evaluating its second program using this platform, SON-1210, an IL12-FHAB-IL15 for solid tumors, in collaboration with the Sarcoma Oncology Center to commence an investigator-initiated and funded Phase 1/2a study for the treatment of pancreatic cancer.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act, as amended, including those relating to the outcome of the Company’s clinical trials, the Company’s cash runway, the Company’s product development, clinical and regulatory timelines, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and other statements that are predictive in nature. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management’s current beliefs and assumptions.

These statements may be identified by the use of forward-looking expressions, including, but not limited to, “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “potential,” “predict,” “project,” “should,” “would” and similar expressions and the negatives of those terms. These statements relate to future events or our financial performance and involve known and unknown risks, uncertainties, and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include those set forth in the Company’s filings with the Securities and Exchange Commission. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

Investor Relations Contact:
JTC Team, LLC
Jenene Thomas
908-824-0775
[email protected]



Goosehead Insurance, Inc. to Report First Quarter 2025 Results

WESTLAKE, Texas, April 16, 2025 (GLOBE NEWSWIRE) — Goosehead Insurance, Inc. (“Goosehead” or the “Company”) (NASDAQ: GSHD) announced today that it will report its first quarter 2025 results after the market close on Wednesday, April 23, 2025.

The company will hold a conference call to discuss results at 4:30 PM ET on April 23rd. To access the call by phone, participants should go to this link (registration link), and you will be provided with the dial in details. A live webcast of the conference call will also be available on Goosehead’s investor relations website at ir.gooseheadinsurance.com.

A webcast replay of the call will be available at ir.gooseheadinsurance.com for one year following the call.

About Goosehead

Goosehead (NASDAQ: GSHD) is a rapidly growing and innovative independent personal lines insurance agency that distributes its products and services through corporate and franchise locations throughout the United States. Goosehead was founded on the premise that the consumer should be at the center of our universe and that everything we do should be directed at providing extraordinary value by offering broad product choice and a world-class service experience. Goosehead represents over 150 insurance companies that underwrite personal and commercial lines. For more information, please visit goosehead.com or goosehead.com/become-a-franchisee.

Contacts

Investor Contact:

Dan Farrell
Goosehead Insurance – VP Capital Markets
Phone: (214) 838-5290
E-mail: [email protected]; [email protected]

PR Contact

Mission North for Goosehead Insurance
Email: [email protected]; [email protected]



MeridianLink Mortgage Streamlines Loan Processing Efficiency for Essex Mortgage

MeridianLink Mortgage Streamlines Loan Processing Efficiency for Essex Mortgage

Seamless integration enables faster decisions and improved client interactions while optimizing operations for Essex Mortgage staff

COSTA MESA, Calif.–(BUSINESS WIRE)–MeridianLink, Inc. (NYSE: MLNK), a leading provider of modern software platforms for financial institutions and consumer reporting agencies, today announced Essex Mortgage has successfully implemented MeridianLink® Mortgage. By replacing its previous loan origination system (LOS) of 10 years with MeridianLink Mortgage, Essex Mortgage has modernized its lending operations, improving efficiency and enhancing the customer experience.

The deployment, completed in just four months, highlights the comprehensive and efficient collaboration between Essex Mortgage’s internal team and MeridianLink’s implementation experts. The smooth transition enabled Essex Mortgage to fully leverage the LOS and achieve greater operational efficiency from day one, including reduced costs and increased client satisfaction.

“The success of this project reflects the dedication and collaboration between Essex Mortgage’s internal team and MeridianLink’s implementation team,” said Leslie Vasquez, IT software manager at Essex Mortgage. “Their responsiveness and expertise helped ensure an on-time transition within our ambitious timeline, allowing us to quickly realize efficiency gains and better serve our customers.”

Essex Mortgage selected MeridianLink Mortgage for its cutting-edge technological advancements, scalability, and cost-effectiveness. The system features an intuitive interface, centralized operations, and powerful automation—benefitting Essex Mortgage employees while driving operational excellence and delivering an improved client experience. In addition, the team appreciated MeridianLink’s culture of collaborative partnership, serving as a trusted technology partner committed to their long-term success.

“This successful implementation demonstrates how financial institutions can improve operational efficiencies and enhance customer service through strategic technology adoption,” said JP Kelly, SVP of Mortgage at MeridianLink®. “We are thrilled to support Essex Mortgage as they continue on their digital progression journey and look forward to continuing our partnership as they maximize the benefits of MeridianLink Mortgage.”

With this implementation, Essex Mortgage is well-positioned to accelerate loan processing, empower staff to focus on delivering more personalized customer service, and streamline backend operations. The MeridianLink Mortgage solution integrated smoothly with Essex Mortgage’s existing systems, enabled by the LOS’ flexible API infrastructure. This allows customers to integrate efficiently on their own timeline, without dependency on vendor-built solutions, enabling a smooth transition while optimizing both operational efficiency and the customer experience.

For more information about MeridianLink’s innovative mortgage lending solutions, visit www.meridianlink.com.

ABOUT MERIDIANLINK

MeridianLink® (NYSE: MLNK) empowers financial institutions and consumer reporting agencies to drive efficient growth. MeridianLink’s cloud-based digital lending, account opening, background screening, and data verification solutions leverage shared intelligence from a unified data platform, MeridianLink® One, to enable customers of all sizes to identify growth opportunities, effectively scale up, and support compliance efforts, all while powering an enhanced experience for staff and consumers alike.

For more than 25 years, MeridianLink has prioritized the democratization of lending for consumers, businesses, and communities. Learn more at www.meridianlink.com.

ABOUT ESSEX MORTGAGE

Since 1986 Essex Mortgage has been a trusted name in full-service mortgage lending by focusing on borrower education and support. This focus combined with their nationwide down payment assistant program and a Servicing division providing best-in-class customer service to tens of thousands of homeowners has made Essex Mortgage one of the most recognized names in the private mortgage sector. Still family owned and operated after nearly forty years, Essex’s focus on doing what’s right for their people speaks for itself. Whether it’s helping borrowers get into their dream home or helping employees find their dream job, their motto of Bringing Families Home is more than just a slogan: it’s how they do business every single day.

PRESS CONTACT

Sydney Wishnow

[email protected]

508-808-9060

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Finance Banking Professional Services Technology Software

MEDIA:

Logo
Logo

QXO Appoints Val Liborski as Chief Technology Officer

QXO Appoints Val Liborski as Chief Technology Officer

GREENWICH, Conn.–(BUSINESS WIRE)–
QXO Inc. (NYSE: QXO) today announced the appointment of global tech veteran Val Liborski as chief technology officer, effective April 21, 2025.

Liborski most recently served as chief technology officer for Yahoo, and prior to that as chief technology officer for HelloFresh. Previously, he led engineering and product management at Amazon Web Services and later oversaw the technology powering the expansion of Amazon’s consumer business across Europe. Earlier in his career, he held senior engineering roles at Microsoft, where he developed large-scale data systems for Bing and advanced AI-driven advertising platforms.

“Val has built his career at high-performance companies where execution is crucial to market leadership,” said Brad Jacobs, chairman and chief executive officer of QXO. “His experience leading world-class teams at some of the most innovative companies in the world gives QXO a major competitive advantage.”

About QXO

QXO plans to become the leader in the $800 billion building products distribution industry, with the goal of generating outsized value for shareholders. The company is targeting annual revenue of $50 billion in the coming decade through accretive acquisitions and organic growth. QXO recently signed a definitive agreement to acquire Beacon Roofing Supply, Inc. for approximately $11 billion, making QXO the second-largest distributor of roofing products in the United States upon closing, expected the week of April 28, 2025. In addition, QXO provides technology solutions to clients in the manufacturing, distribution and service sectors. Visit www.qxo.com for more information.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements. Statements that are not historical facts, including statements about beliefs, expectations, targets or goals, the expected timing of the closing of the proposed acquisition, the anticipated benefits of the proposed acquisition and expected future financial position and results of operations, are forward-looking statements. These statements are based on plans, estimates, expectations and/or goals at the time the statements are made, and readers should not place undue reliance on them. In some cases, readers can identify forward-looking statements by the use of forward-looking terms such as “may,” “will,” “should,” “expect,” “opportunity,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “target,” “goal,” or “continue,” or the negative of these terms or other comparable terms. Forward-looking statements involve inherent risks and uncertainties and readers are cautioned that a number of important factors could cause actual results to differ materially from those contained in any such forward-looking statements. Factors that could cause actual results to differ materially from those described herein include, among others: (i) the risk that the proposed acquisition may not be completed on the anticipated terms in a timely manner or at all; (ii) the failure to satisfy any of the conditions to the consummation of the proposed acquisition, including uncertainties as to how many of stockholders of Beacon Roofing Supply, Inc. (“Beacon”) will tender their shares in the tender offer; (iii) the effect of the pendency of the proposed acquisition on each of QXO’s and Beacon’s business relationships with employees, customers or suppliers, operating results and business generally; (iv) the occurrence of any event, change or other circumstance or condition that could give rise to the termination of the merger agreement, including circumstances that require Beacon to pay a termination fee; (v) the possibility that the proposed acquisition may be more expensive to complete than anticipated, including as a result of unexpected factors or events, significant transaction costs or unknown liabilities; (vi) potential litigation and/or regulatory action relating to the proposed acquisition; (vii) the risk that the anticipated benefits of the proposed acquisition may not be fully realized or may take longer to realize than expected; (viii) the impact of legislative, regulatory, economic, competitive and technological changes; (ix) QXO’s ability to finance the proposed transaction, including the ability to obtain the necessary financing arrangements set forth in the commitment letters received in connection with the proposed acquisition; (x) unknown liabilities and uncertainties regarding general economic, business, competitive, legal, regulatory, tax and geopolitical conditions; and (xi) the risks and uncertainties set forth in QXO’s and Beacon’s SEC filings, including each company’s Annual Report on Form 10-K for the year ended December 31, 2024 and subsequent Quarterly Reports on Form 10-Q.

Forward-looking statements should not be relied on as predictions of future events, and these statements are not guarantees of performance or results. Forward-looking statements herein speak only as of the date each statement is made. QXO and Beacon do not undertake any obligation to update any of these statements in light of new information or future events, except to the extent required by applicable law.

Media Contact:

Joe Checkler

[email protected]

203-609-9650

Investor Contact:

Mark Manduca

[email protected]

203-321-3889

KEYWORDS: United States North America Connecticut

INDUSTRY KEYWORDS: Architecture Internet Data Management Other Construction & Property Technology Residential Building & Real Estate Construction & Property Trucking Urban Planning Building Systems Transport Other Technology

MEDIA:

Logo
Logo